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 End-stage renal disease (ESRD) is one of the public health problems in 
Indonesia. This study aimed to determine the clinical condition of premorbid 
and the incidence of ESRD. The study design is a case-control. The number of 
volunteers involved in this study was 100 patients. The cases were ESRD 
patients who were determined by the criteria of Pernefri and the controls were 
patients from the same hospital who were not ESRD by the requirements of 
ESRD Pernefri. Inclusion criteria of the study sample were ESRD sufferers 
need routine hemodialysis and doctor's diagnosis supported by laboratory data, 
15-75 years old and willing to fill out inform consent. Exclusion criteria for 
the study sample were patients with congenital kidney disease, Have a history 
of kidney transplants, and mental disorder. We collected demographic data, 
and patient’s clinical and drug history from medical records.  
Chi-square analysis with 2x2 tables and the Fisher's exact test were used to 
determine the relationship of clinical conditions and history of disease with  
the incidence of ESRD. The results showed that anemia, hyperglycemia,  
and hypertriglyceridemia were related to the prevalence of ESRD. History of 
hypertension, diabetes mellitus, dyslipidemia, and family history of ESRD are 
associated with an increased incidence of ESRD. 
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1. INTRODUCTION  
End-stage renal disease (ESRD) now and in the future is world health problems including in  
Indonesia [1-2]. Terminal chronic renal failure occurs when the glomerular filtration rate (LFG) is less than 15 
ml/minute/1.73 m2 for three months or more or creatinine clearance<5 ml/minute and serum creatinine levels 
are more than or equal to 10 mg/mL [3-5]. In Indonesia, the incidence and prevalence of ESRD are at 100-150 
and 200-250 per 1 million population per year. It was determined that there were more than 7,000 ESRD 
patients in Indonesia [6-8]. The mortality rate of patients with ESRD 5-10x is not ESRD.  
The mortality rate of ESRD patients in the first year of illness reached 20% and increased to 60% in the fifth 
year [9-12]. In 2030 ESRD is estimated to contribute 30% to the cause of death in the world [1, 11, 13].  
Besides the increasing incidence, prevalence, and mortality rate of ESRD, what needs to be considered is  
the significant cost of care for ESRD patients [14-15]. ESRD does not only cause physical, economic and 
psychological damage to sufferers but also a burden on families, as well as the state so that efforts are 
preventive and promotive [7, 16]. In line with the results of other studies, previous reseracher [17] reported 
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that nearly 50% of ESRD patients who do hemodialysis at PKU Muhammadiyah Yogyakarta hospital have a 
low quality of life [14, 18]. 
Until now, treatment or treatment of patients with ESRD rests on two actions, namely kidney 
transplantation or undergoing dialysis to replace permanently damaged kidney function [19]. Both kidney 
transplantation and hemodialysis are actions that require high costs, and the results are not satisfactory.  
Due to the increasing number of ESRD sufferers in Indonesia, it is necessary to develop a preventive and 
promotive program in the field of nephrology. Identifying premorbid clinical risk factors and other biological 
factors as a basis for clinical decision making should be identified [6, 20-22]. However, not all ESRD risk 
factors in Indonesia have yet to be identified. Therefore this research needs to be done in Indonesia.  
The purpose of the study, in general, was to determine the relationship of premorbid clinical conditions with 
the incidence of ESRD. 
 
 
2. RESEARCH METHOD  
2.1.  Type and design of the study 
This study was an observational analytic study with a case-controlled design. ESRD patients as a case 
group, while non ESRD volunteers who are by or without smoking as a control. Data gathered at PKU 
Muhammadiyah Yogyakarta Hospital, Bantul public Hospital, Sleman public Hospital, and Panti Rapih 
Hospital in Special Region of Yogyakarta (SRY). 
 
2.2.  Research subject 
The population was patients diagnosed with terminal chronic renal failure for no more than three 
months, with diagnostic criteria namely creatinine clearance<5ml/minute or blood serum creatinine level 
greater or equal to 10 mg/dl which can be known from medical records and requires continuous hemodialysis. 
Inclusion criteria for research subjects: Indonesians (Javanese, Sundanese, Malay); ages 15-65 years old; 
willing to participate in research by filling out and signing the agreement and cooperative statement sheets; 
and new ESRD patients namely establishing a diagnosis of ESRD in patients with or less than three months. 
Research subjects who have been selected through inclusion criteria will be excluded from the study subjects 
if: have congenital kidney disease, kidney transplant history, mental illness. The minimum number of samples 
needed for the case is 44 people. With a comparison of between cases and control is 1:2, the number of controls 
group is 88 patients. The minimum number of research subjects is 132 people. Sampling is done by consecutive 
random sampling. 
 
2.3.  Tools and materials. 
The tools and materials in this study include equipment for primary data collection (questionnaires), 
secondary data collection forms, chemicals, and glassware. 
 
2.4.  Operational variables and definitions of research 
Independent variables were gender, body weight (BW), age and smoking activity as well as blood 
cotinine levels. The dependent variable is ESRD. Terminal chronic kidney disease is a persistent (more than 
three months) kidney function disorder and requires a kidney transplant or routine dialysis to replace kidney 
function; kidney abnormalities are measured by a decrease in GFR<5 ml/minute or serum creatinine levels 
greater than or equal to 10 mg/dL. YES if the respondent meets laboratory criteria or requires a kidney 
transplant or undergoes hemodialysis. NO, if the respondent does not meet laboratory criteria or needs  
a kidney transplant or undergoing hemodialysis. 
 
2.5.  Collection data procedure 
Measuring instruments used in this study include (i) Questionnaire, used to obtain primary data 
demographic characteristics and smoking habits of respondents. (ii) The data collection form is used to collect 
secondary data taken from medical record books or patient status which include name, age, gender,  
previous pain and medication diagnosis data, laboratory data and patient clinical manifestations. 
 
2.6.  Operational limitations 
In general, data collection in this study was carried out by interviews, observation, and direct 
measurements. Primary data about ESRD pain history and smoking history were collected by structured 
interviews with guided questionnaires. Original data about the characteristics and clinical manifestations of  
the subject is obtained by direct measurement. Secondary data on demographic characteristics and pain history 
and treatment of research subjects were taken from medical records and supplemented by interviews with 
assisted forms of data collection and questionnaires. 
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The implementation phase includes activities in the field as well as in the laboratory as follows:  
(i) Primary data collection in the sample by interview using a questionnaire provides for the identity of  
the respondent, socio-economic, smoking behavior, disease data obtained from the patient's medical record and 
other related data with research variables. Subjects/volunteers who have fasted 8-12 hours measured blood 
pressure, waist circumference, body weight, and height for the determination of body mass index (BMI). 
Prospective subjects who met the inclusion criteria have explained the purpose of the study and were asked to 
fill out an informed consent sheet as proof of the participation of the subjects in the research and fill out  
the questionnaire. The case/control subjects were taken for 5 ml of blood from the anterior cubital median vein.  
3 ml of blood was centrifuged at 3000 g for 15 minutes. The serum is used to examine creatinine, BUN,  
random blood glucose, triglyceride, cholesterol levels, and other examinations. Examination of creatinine and 
laboratory levels was carried out by the spectrophotometer method, as was done by previous researchers [23]. 
 
2.7.  Data analysis 
Chi-square analysis with 2x2 or 3x2 tables with Fisher's exact test was used to assess the relationship 
of clinical or biological conditions and illness history to the incidence of ESRD. 
 
2.8.  Research ethics 
Because it involves human respondents, it explained to all prospective respondents about the purpose 
and objectives of the research, the benefits and expected uses and the consequences of the respondent  
(informed consent), in addition to the management of ethical clearance (No KEPK/847/EC).  
 
 
3. RESULTS AND DISCUSSIONS  
3.1.  Overview of respondents 
The research subjects consisted of 53 ESRD patients as the cases and 106 non ESRD patients as  
the controls, originating from 4 hospitals in Special Region of Yogyakarta (SRY), namely PKU 
Muhammadiyah Yogyakarta private Hospital, Sleman regional public Hospital, and Bantul regional public 
Hospital. The demographic conditions of research subjects according to age group, sex, type of work, and level 
of education as well as those responsible for medical expenses are presented in Table 1. 
 
 
Table 1. The demographic characteristics of ESRD patients in the Special Region of Yogyakarta. 
No Respondents characteristics 
Respondent status 
Total P 
Cases (CKD) Control 
1 Hospital 
PKU Yogyakarta hospital 19 (33.3% ) 38 (66.7% ) 57 (100% ) 
1 
PKU Gamping hospital 6 (33.3% ) 12 (66.7%) 18 (100% ) 
Bantul regional hospital 25 (33.3% ) 50 (66.7%) 75 (100% ) 
Sleman regional hospital 3 (33.3% ) 6 (66.7% ) 9 (100% ) 
2 Sex 
Male 35 (33.3% ) 70 (66.7%) 105 (100% ) 
0.568 
Female 18 (33.3% ) 36 (66.7% ) 54 (100% ) 
3 Age group 
16-30 year 5 (31.2% ) 11 (68.8% ) 16 (100% ) 
0.998 
31-45 year 15 (33.3% ) 30 (66.7% ) 45 (100% ) 
46-60 year 25 (33.8% ) 49 (66.2%) 74 (100% ) 
>60 year 8 (33.3% ) 16 (66.7%) 24 (100% ) 
4 Education 
No 3 (21.4%) 11 (78.6% ) 14 (100%) 
0.267 
elementary 14 (28.0% ) 36 (72.0%) 50 (100%) 
Yunior high school 5 (21.7% ) 18 (78.3% ) 23 (100%) 
Senior high school 21 (44.7% ) 26 (55.3% ) 47 (100%) 
University 10 (33.3% ) 15 (66.7% ) 9 (100%) 
5 Job 
Military, police or Government employees 13 (52.0%) 12 (48%) 25 (100%) 
0.085 
Private and self-employed 9 (36.0%) 16 (64.0%) 25 (100%) 
Farmers, laborers, and artisans 15 (23.8%) 48 (76.2%) 63 (100%) 
No job 16 (34.8%) 30 (65.2%) 46 (100%) 
6 Assurance 
No 1 (5.3%) 18 (94.7%) 19 (100%) 
0.001 Private health Assurance 19 (54.3%) 16 (45.7%) 35 (100%) 
Public health assurance 33 (31.4%) 72 (68.6%) 105 (100%) 
7 
Marital 
status 
Yes 52 (33.5%) 103 (66.5%) 155 (100%) 
0.593 
No 1 (25.0%) 3 (75.0%) 4 (100%) 
 
 
Most of the research subjects were between 46-60 years old (50.3%), followed by the general  
group 31-45 years (27%). >60 years (18.2%) and 16-30 years (7.4%). The difference in the distribution of 
research subjects based on age groups between ESRD patients and not ESRD was not different (p>0.05). 
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3.2.  Overview of respondents' clinical conditions 
An overview of clinical and laboratory conditions is presented in Table 2. The table shows that  
the average Hb, erythrocytes, leukocytes, and hematocrit levels of the ESRD group were lower than the control 
group (p<0.05). Blood glucose, urea, and creatinine levels in the ESRD group were higher than the control 
group (p<0.05). Anemia is one of the distinguishing factors in handling ESRD patients [24]. 
 
 
Table 2. Clinical and laboratory conditions of ESRD patients  
No Respondents characteristic Cases Control p 
1 Age 48.34±11.15 48.18±11.32 0.962 
2 Body weight 57.23±8.06 57.62±9.01 0.787 
3 BMI 22.21±2.79 22.33±3.27 0.809 
4 Hb level 8.24±1.46 12.93±1.81 0.000* 
5 Eritrocytes 2.89±0.56 4.58±0.58 0.000* 
6 Leucocytes 7.08±2.06 9.24±3.21 0.000* 
7 Thrombocytes 242.26±65.23 249.33±68.17 0.533 
8 Haematocrit 23.54±2.90 38.73±5.62 0.000* 
9 Blood glucose ad random (RBG) 120.87±23.22 107.72±13.87 0.000* 
10 hypertriglyseridemia 118.46±56.18 115.63±38.18 0.742 
11 Ureum level 155.76±42.81 21.65±7.82 0.000* 
12 Creatinine level 8.83±2.97 0.75±0.24 0.000* 
13 Glomerular filtration rate (GFR) 5.81±2.97 104.89±20.05 0.000* 
Note:*=p<0.05 
 
 
3.3.  Bivariate analysis of clinical and biological conditions with ESRD events 
The relationship of the biological and clinical characteristics of respondents with the incidence of 
ESRD is presented in Table 3. This table reveals that the incidence of ESRD is related to clinical conditions. 
Anemia is related to the incidence of ESRD Anemic conditions (Hb<12 mg%) have a 37x ESRD risk compared 
to not anemic. RBG status>120 mg/ml increases the risk of ESRD 2.79x (p<0.05). The condition of 
hypertriglyceridemia (TG level>200 mg/dl) increases the risk of ESRD 5.42x. The body mass index is not 
related to the incidence of ESRD. The results of the study are in line with other studies [23, 25]. 
 
 
Table 3. Relationship between the clinical characteristic (BMI, haemoglobin, RBG, and triglycerides)  
with ESRD events  
Clinical biology characteristic Cases controlled Total OR; CI;95% P 
BMI classification 
Lean 6(31.6%) 13(68.4%) 19(100%) 1 0.856 
Normal 37(35.6%) 67(64.4%) 104(100%) 0.84 (.29-2.38) 0.737 
Fat 6(28.6%) 15(71.4%) 21(100%) 1.15 (.29-4.47) 0.836 
Obesity 4(26.7%) 11(73.3%) 15(100%) 1.27 (.28-5.68) 0.755 
Hb level 
<12 51(54.3%) 43(45.7%) 94(100%) 
37 (8.63-161.68) 0.000 
>=12 2(3.1%) 63(96.9%) 65(100%) 
RBG 
>120 21(51.2%) 20(48.8%) 41(100%) 
2.79 (1.337-5.817) 0.005 
<=120 32(27.4%) 85 (72.6%) 117(100%) 
Hypertrilgeridemia 
>200 5(71.4%) 2(28.6%) 7(100%) 
5.42 (1.014-8.922) 0.042 
<=200 48(31.6%) 104(68.4%) 152(100%) 
 
 
3.4.  Bivariate analysis relationship between respondent's history and ESRD events 
Pre-morbid conditions that increase the risk of ESRD events are presented in Table 4. The results of 
the study showed that some history of the disease was related to the incidence of ESRD. History of DM, 
hypertension, hypercholesterolemia has been shown to increase the incidence of ESRD. The family history of 
the ESRD is also related to the prevalence of ESRD. Opportunities for ESRD events in respondents with  
a history of DM 34x than without a history of DM. Opportunities for ESRD events in respondents with a history 
of hypertension 8x than respondents did not have a history of hypertension. Family history of ESRD pain is 
8.6 times more than families without a history of ESRD. The results of the study are in accordance with  
the results of previous studies [1, 26], except obesity. Diabetes mellitus (DM), hypertension (HTN),  
obesity and cardiovascular disease have attributed to the rapid rise in the incidence of CKD in most parts of 
the world, especially in developing countries [1]. 
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Table 4. Relationship of previous illness history with ESRD events in respondents  
Illness history  Cases controlled Total OR, CI 95% p 
DM 
Yes 21 (91.3%) 2(8.7%) 23 (100%) 34 (7.58–153.48) 0.000 
no 32 (23.5% 104 (76.5%) 136(100%)   
Hypertension 
Yes 37(62.7%) 22(37.3%) 59 (100%) 8 (4.17-18.71) 0.000 
no 16(16.0%) 84(84.0%) 100 (100%)   
Hipercholesterolemia 
Ya 18(58%) 13(42%) 31(100) 3 (1.6–8.29) 0.001 
Tidak 35(27%) 93(73%) 128(100%)   
ESRD in family 
Yes 4(80%) 1(20%) 5 (100%) 8 (0.93–78.71) 0.043 
No 49(31.8%) 105(68.2%) 154 (100%)   
 
 
4. CONCLUSION 
The clinical conditions of hyperglycemia, hypertriglyceridemia, and anemia are associated with  
the incidence of ESRD. History of diabetes, hypercholesterolemia, hypertension, and family history with ESRD 
are also related to the prevalence of ESRD. 
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